NBTX
Nanobiotix
NASDAQ: NBTX · HEALTHCARE · BIOTECHNOLOGY
$32.99
-0.39% today
Updated 2026-04-29
Market cap
$1.60B
P/E ratio
—
P/S ratio
49.09x
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$3 – $42
Volume
0.1M
Nanobiotix (NBTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.36M | $970608.00 | $1.60M | $2.77M | $4.02M | $5.42M | $3.72M | $3.48M | $2.54M | $2.33M | $2.65M | $4.78M | $36.21M | $-7.19M | $29.64M |
| Revenue growth (YoY) | — | -28.6% | +64.4% | +73.7% | +44.9% | +35.0% | -31.3% | -6.5% | -27.0% | -8.5% | +13.8% | +80.4% | +658.1% | -119.9% | +512.3% |
| Cost of revenue | — | — | — | — | $359611.00 | $436307.00 | $345591.00 | — | — | — | — | $985000.00 | — | — | — |
| Gross profit | $1.36M | $970608.00 | $1.60M | $2.77M | $4.02M | $5.42M | $3.72M | $3.48M | $2.54M | $2.33M | $2.65M | $4.78M | $36.21M | $-7.19M | $29.64M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $5.21M | $4.31M | $6.03M | $8.08M | $13.90M | $16.92M | $17.73M | $20.89M | $30.41M | $24.33M | $30.38M | $32.64M | $38.40M | $40.54M | $23.11M |
| SG&A | $1.30M | $1.81M | $3.15M | $4.06M | $7.19M | $10.26M | $12.34M | $12.62M | $18.64M | $14.27M | $19.43M | $17.48M | $21.66M | $20.06M | $20.22M |
| Operating income | $-5.23M | $-5.15M | $-8.18M | $-9.62M | $-17.14M | $-21.85M | $-25.27M | $-30.07M | $-46.78M | $-36.43M | $-52.58M | $-46.70M | $-26.78M | $-68.39M | $-10.82M |
| Operating margin | -384.3% | -530.9% | -512.7% | -347.2% | -426.9% | -403.1% | -678.9% | -864.2% | -1841.0% | -1566.8% | -1986.4% | -977.8% | -74.0% | 951.2% | -36.5% |
| EBITDA | $-5.02M | $-5.01M | $-7.95M | $-9.31M | $-16.69M | $-21.37M | $-24.81M | $-29.45M | $-45.01M | $-34.86M | $-45.60M | $-44.22M | $-23.69M | $-67.67M | $-12.07M |
| EBITDA margin | -368.9% | -515.8% | -498.0% | -336.1% | -415.6% | -394.2% | -666.6% | -846.5% | -1771.4% | -1499.4% | -1722.9% | -925.8% | -65.4% | 941.1% | -40.7% |
| EBIT | $-5.22M | $-5.15M | $-8.18M | $-9.62M | $-17.14M | $-21.85M | $-25.27M | $-30.07M | $-46.78M | $-36.62M | $-47.16M | $-45.72M | $-24.24M | $-68.26M | $-13.56M |
| Interest expense | $30768.00 | $77005.00 | $24570.00 | $55726.00 | $59517.00 | $102203.00 | $108367.00 | $847000.00 | $4.79M | $333000.00 | $699490.00 | $5.84M | $7.98M | $8.09M | $10.39M |
| Income tax | $30670.00 | $78889.00 | $22909.00 | $79271.00 | $37578.00 | $90425.00 | $20.00 | $-449000.00 | $3000.00 | $9000.00 | $5000.00 | $10000.00 | $120000.00 | $101000.00 | — |
| Effective tax rate | -0.6% | -1.5% | -0.3% | -0.8% | -0.2% | -0.4% | -0.0% | 1.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.3% | -0.1% | 0.0% |
| Net income | $-5.25M | $-5.33M | $-8.14M | $-9.56M | $-17.00M | $-21.88M | $-26.14M | $-30.34M | $-50.91M | $-33.59M | $-47.00M | $-57.04M | $-39.70M | $-68.13M | $-23.96M |
| Net income growth (YoY) | — | -1.6% | -52.8% | -17.3% | -77.9% | -28.7% | -19.5% | -16.1% | -67.8% | +34.0% | -39.9% | -21.4% | +30.4% | -71.6% | +64.8% |
| Profit margin | -385.7% | -549.2% | -510.5% | -344.9% | -423.5% | -403.6% | -702.4% | -872.2% | -2003.7% | -1444.7% | -1775.7% | -1194.3% | -109.6% | 947.6% | -80.8% |